{"nct_id":"NCT00697216","title":"Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).","status":"COMPLETED","status_verified_date":"2008-06","start_date":"1997-03","start_date_type":null,"primary_completion_date":"1999-03","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE3"],"tickers":["GSK"]}